Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier

Abstract

The blood-brain barrier (BBB), the unusual microvascular endothelial interface between the central nervous system (CNS) and the circulatory system, is a major hindrance to drug delivery in the brain parenchyma. Besides the absence of fenestrations and the abundance of tight junctions, ATP-binding cassette (ABC) transporters critically reduce drug entry within the CNS, as they carry many drugs back into the bloodstream. Nanoparticle- and liposome-carried drugs, because of their increased cellular uptake and reduced efflux through ABC transporters, have been developed in recent times to circumvent the low drug permeability of the BBB. This review discusses the role of ABC transporters in controlling drug penetration into the brain parenchyma, the rationale for using nanoparticle- and liposome-based strategies to increase drug delivery across the BBB and new therapeutic strategies for using nanoparticle- and liposome-carried drugs in different conditions, ranging from CNS tumors and neurodegenerative diseases to viral infections and epilepsy.

The Nasal Approach to Delivering Treatment for Brain Diseases: An Anatomic, Physiologic, and Delivery Technology Overview

“…These approaches may allow transport via receptor-mediated transfer (RMT) systems in the BBB [3,4]. An alternative or supplementary approach is targeted intranasal delivery, an approach potentially applicable…”

Regenerative nanomedicine: current perspectives and future directions

“…Nanoparticles reach the brain parenchyma evading these mechanisms, thus making them favorable for neuronal drug delivery. 69 Surface-modified chitosan nanogels loaded with methotrexate injected in animals have shown higher concentration of nanogelincorporated drug in the brain compared with the raw drug, but no difference in concentration due to surface modification. This indicates that nanogels can be utilized for drug delivery into the CNS, due to their efficiency in crossing the BBB effectively.…”

Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines

“…178 Liposomes can also be used for virus free transfection to generate induced pluripotent cells, 179 gene delivery to mesenchymal stem cells, 180 targeting peripheral neurons and Schwann cells for enhanced uptake 181 and targeting the CNS. 182,183 Similarly, dendrimers are macromolecules of nanoscale dimensions with a central core, branched intermediate structure and then exterior functional groups. Combinations of various properties of these hierarchial components make dendrimers very promising candidates for drug delivery systems.…”